跳至主要内容
临床试验/NCT03916471
NCT03916471Unknown不适用

Comparison of Efficacy and Side Effects Between the Obtryx and Solyx Band With 5-year Follow-up. Prospective, Randomized and Non-inferiority Study

Instituto de Investigacion Sanitaria La Fe1 个研究点 分布在 1 个国家目标入组 166 人开始时间: 2018年12月21日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
166
试验地点
1
主要终点
Continence rate (Objective) assessed by an effort test

研究概览

简要总结

Boston2018 post-market clinical study is a prospective, randomized, non-inferiority study to assess the efficacy and adverse events of the Solyx™ Single Incision Sling (SIS) System compared to the gold-standard Obtryx™ II Sling System, in patients with stress urinary incontinence (SUI) and long-term follow-up (5 years).

详细描述

Randomized prospective non-inferiority study, in which we evaluate patients with stress urinary incontinence (SUI) who undergo surgical treatment consisting of a minimal incision in the suburethral area of the vaginal mucosa for a mesh insertion in order to:

Main Objective:

To compare the continence rate (objective) between Solyx and Obtryx II meshes in patients with SUI. This rate will be determined by an effort test.

Secondary Objectives:

  • To compare the continence rate (subjective) between both meshes.
  • To compare variations in Pad-Test.
  • To asses patient satisfaction.
  • To evaluate both techniques regarding quality and sexual life modifications.
  • To compare both techniques regarding early complications (up to 30 days post implantation).
  • To compare the appearance and persistence of late complications (from 30 days onwards).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patients diagnosed with symptomatic stress urinary incontinence candidates for stress-free bands
  • Age > or = 40 years
  • informed consent signed by the patient

排除标准

  • patients who are pregnant or wish to become
  • patients who need anticoagulant
  • active vaginal or urinary infection
  • previous surgical interventions for the treatment of incontinence
  • body mass index > 35

结局指标

主要结局

Continence rate (Objective) assessed by an effort test

时间窗: Year 5

For the analysis of the objective cure of incontinence, an effort test will be carried out through three strokes of cough, with bladder volume between 200-300 ml in a lithotomy position.

次要结局

  • Pad test(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Evaluation of sexual life, assessed by PSIQ 12 questionnaire (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire )(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Early complications assessed by Post-Mictional Residue(Day 0, 7-10 days after the intervention, Month 1)
  • Patient satisfaction assessed by PGI-I (Patient Global Impression of Improvement)(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Patient satisfaction assessed by the "Global Satisfaction Test"(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Patient satisfaction assessed by the "Recommendations questionnarie"(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Continence rate (Subjective) assessed by Incontinence Questionnaire-Urinary Short Form (ICQ-SF)(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Early complications assessed by OAB-q questionnaire (Overactive Bladder symptom and health-related quality of life questionnaire)(Day 0, 7-10 days after the intervention, Month 1)
  • Long term complications assessed by "Extrusion" (integrity of the vaginal mucus)(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Long term complications assessed by "Emptying dysfunction"(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Evaluation of life quality improvement assessed by I-QoL questionnaire (Urinary Incontinence-Specific Quality of Life Instrument)(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Long term complications assessed by emergence of recurrent urinary tract infections (UTIs)(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Long term complications assessed by OAB-q questionnaire (Overactive Bladder symptom and health-related quality of life questionnaire)(Month 1, month 6, year 1, year 2, year 3, year 4 and year 5.)
  • Early complications assessed by VAS (Visual Analogue Scale)(Day 0, 7-10 days after the intervention, Month 1)

研究者

发起方
Instituto de Investigacion Sanitaria La Fe
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验